Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

F. S. Mennini, A. Marcellusi, G. Fabiano, F. Platini, P. Bossi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences